Postoperative Analgesia After Elective Hip Surgery - Effect of Obturator Nerve Blockade

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-15

Study Completion Date

2018-06-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates the effect of an obturator nerve block on the postoperative pain and opioid consumption after total hip replacement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Obturator Nerve Block in Patients With Hip Fracture

NCT02408419

Hip Fractures

WITHDRAWN PHASE4

Obturator and Femoral Nerve Block in Patients With Hip Fracture

NCT02540837

Hip Fractures

UNKNOWN PHASE4

Total Hip Arthroplasty: Multiple Blocks by UltraSound

NCT01276925

Pain, Postoperative

UNKNOWN NA

Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty

NCT02344264

Pain, Postoperative Ropivacaine Therapeutic Use +1 more

COMPLETED PHASE4

Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy

NCT02346357

Pain

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obturator Nerve Block Total Hip Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obturator nerve block

Postoperative obturator nerve block with 15 mL bupivacain 5 mg/mL and epinephrine 5 µg/mL.

Group Type EXPERIMENTAL

Bupivacaine-epinephrine

Intervention Type DRUG

Nerve block with 15 mL bupivacain 5 mg/mL with epinephrine 5 µg/mL.

Obturator nerve block

Intervention Type PROCEDURE

Postoperative obturator nerve block

Sham block

Postoperative sham-block with normal saline.

Group Type PLACEBO_COMPARATOR

Sham block

Intervention Type PROCEDURE

Injection as for obturator nerve block, but with placebo

Sodium Chloride 9mg/mL

Intervention Type DRUG

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine-epinephrine

Nerve block with 15 mL bupivacain 5 mg/mL with epinephrine 5 µg/mL.

Intervention Type DRUG

Sham block

Injection as for obturator nerve block, but with placebo

Intervention Type PROCEDURE

Obturator nerve block

Postoperative obturator nerve block

Intervention Type PROCEDURE

Sodium Chloride 9mg/mL

Placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients for primary hip replacement in spinal anesthesia
* Age \>= 18 years
* American Society of Anesthesiologists physical status classification score I-III
* Informed consent

Exclusion Criteria

* Lacking the ability to corporate
* Lacking the ability to speak danish
* Planned discharge on the same day of surgery
* Neuropathy of the lower extremities
* Contraindications for NonSteroidal Anti-Inflammatory Drugs (NSAID)
* Contraindications for dexamethasone
* Chronic opioid demanding pain
* Pregnancy
* Allergy towards one or both investigatory medicinal products
* Active treatment with amiodarone
* Active treatment with verapamil
* Active treatment with corticosteroids

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No